Bridgesheet

Financial modelling7 min read

Control Premium: Calculation, Reference Price, Synergies

The control premium is the gap between the price an acquirer offers and the target's share price before the announcement. Its level depends on the reference price chosen, and it is only justified if the expected synergies cover it.

Wooden chessboard with all the pieces in their starting position
Photo: Wilfredor · CC0 · Wikimedia

What the control premium measures

The control premium is the extra an acquirer pays above the share price to take a majority or all of a listed company. It is calculated in one line:

Premium = offer price per share ÷ reference price − 1

The share price is the price of a small quantity of shares, traded between investors who do not run the company. The acquirer, by contrast, is buying the right to decide: to appoint the management, set the dividend, sell a plant, merge two sales networks. That right has a value, and it has to be paid for to persuade shareholders to tender their shares rather than keep them.

On public offers, the order of magnitude often quoted is 20% to 40% above the unaffected share price. It is not a rule: the premium on a given deal depends on competition between bidders, on synergies, on the target's shareholder base and on the reference price used. That last point is the one that most often distorts comparisons.

The example: an offer for Solvane

Take Solvane, a fictional listed industrial services company. Its figures before the offer:

Item Value
Diluted shares 40 million
Share price the day before the first rumours €25.00
Market capitalisation at that price €1,000m
Net debt €500m
EBITDA (operating profit before depreciation and amortisation) €200m

An industrial group in the same sector announces an offer at €32.00 per share, or €1,280m for all of the shares.

Step 1: choose the reference price

A premium only means something if it is measured against a price that does not already contain the offer. This "unaffected" price is the one before any leak or rumour, not necessarily the price the day before the announcement. It is supplemented by volume weighted average prices (VWAP), which smooth out the swings of a single trading session.

For Solvane, the shares rose to €28.40 in the days before the announcement, on rumours. Here is the premium under each reference:

Reference price Price Premium at €32.00
Day before announcement (after rumours) €28.40 12.7%
Day before first rumours (unaffected) €25.00 28.0%
1-month VWAP before the rumours €24.20 32.2%
3-month VWAP €23.50 36.2%
6-month VWAP €22.80 40.4%

The same price gives a premium of 13% or of 40%. The buyer's advisers will want to quote the first, the target's advisers the last. In a model, always show several references and state the date you treat as unaffected. When you compare the premium with that of other deals, use the same reference throughout.

Step 2: move from the premium on shares to enterprise value

The premium is calculated on the price of the shares. But the acquirer also takes on the debt: what it pays for the whole business is the enterprise value (EV), that is the value of the shares plus net debt.

Before the offer At the offer price
Value of the shares €1,000m €1,280m
Net debt €500m €500m
Enterprise value €1,500m €1,780m
EV / EBITDA 7.5x 8.9x

The premium in euros is €280m. Set against an enterprise value of €1,500m, it represents only 18.7%, against 28.0% on the shares. Debt does not change in value when the offer arrives: the more indebted the target, the less a given premium on the shares weighs on EV.

This difference matters when comparing deals. A 28% premium on a company with no debt and a 28% premium on an indebted company do not represent the same effort by the acquirer. The EV/EBITDA multiple paid, here 8.9x, compares better from one deal to the next, and it is the figure you find in precedent transactions.

Step 3: compare the premium with the synergies

A control premium can be justified in two ways. Either the acquirer thinks the target is badly run and that it will get more out of it on its own, or it expects synergies, that is gains that only exist if the two companies are combined (joint purchasing, merged sites, cross-selling). In both cases, the premium is a payment in advance for a future gain. Our article on acquisition synergies shows how to value these gains line by line.

The acquirer of Solvane expects €30m a year of pre-tax cost savings, or €22.5m after tax at 25%. They build up over three years (one third in year one, two thirds in year two, the full amount thereafter) and integration costs €40m in the first year, or €30m after tax. Discounted at a cost of capital of 9%, with no growth:

Item Calculation Present value
Synergies, year 1 7.5 ÷ 1.09 €6.9m
Synergies, year 2 15.0 ÷ 1.09² €12.6m
Synergies from year 3 (22.5 ÷ 9%) ÷ 1.09² €210.4m
Integration costs − 30.0 ÷ 1.09 − €27.5m
Net synergies €202.4m

The premium paid, €280m, exceeds the value of all the synergies by €78m. At €32.00, the acquirer is giving Solvane's shareholders more than the deal is expected to earn it. The maximum price that does not destroy value for the acquirer would be:

(1,000 + 202.4) ÷ 40 = €30.06 per share, a premium of 20.2%

Beyond that, the deal can only be defended if Solvane is worth more than its share price for other reasons, which has to be shown with a DCF of the target on a standalone basis. In practice, a disciplined acquirer tries to keep part of the synergies for its own shareholders: if it handed over half, it would offer (1,000 + 101.2) ÷ 40 = €27.53, a premium of 10.1%. The effect on the acquirer's earnings per share is then checked in an accretion dilution model.

Using the control premium in a valuation

Each valuation method produces a value at a specific level. Adding or forgetting the premium amounts to mixing those levels.

Method What the result contains Add a control premium?
Trading comparables Price of a minority stake, tradable on the market Yes, to estimate the price of 100% of the share capital
Precedent transactions Price paid for control, shared synergies included No, it is already in there
DCF on management's plan Value of the company on its own, run as it is today Only if the acquirer can do better
DCF on the acquirer's plan Value to that acquirer, improvements and synergies included No, that would count it twice

For an unlisted SME, the question is the other way round. A multiple taken from listed companies gives a liquid minority value. The sale of 100% of an SME is a change of control, but its shares cannot be resold on a market and the company is often smaller than the listed ones. An illiquidity discount then works in the opposite direction to the premium, and the two do not simply add up: each has to be justified.

Mistakes that distort the control premium

  • Measuring the premium on a price already inflated by rumours. The premium looks low and the offer looks cheap. Go back to the unaffected date and say which one you use.
  • Comparing premiums calculated on different references. A premium on the day before the announcement and a premium on the six-month average cannot be compared.
  • Confusing the premium on shares with the premium on enterprise value. On an indebted target, the gap is significant. The EV/EBITDA multiple paid remains the most comparable measure.
  • Applying an average premium without looking at the synergies. An average of past deals does not tell you what this acquirer can pay. The ceiling comes from its synergies, not from the market average.
  • Adding the premium to a value that already contains it. A transaction multiple or a DCF built on the acquirer's plan already includes control.
  • Forgetting integration costs. They reduce the value of the synergies, here by €27.5m, and they arrive before the gains.

Our merger Excel model starts from the premium offered and calculates the acquirer's pro forma earnings per share, the accretion or dilution depending on the method of payment, the synergies that make the deal break even and the goodwill. It is a calculation tool: the result remains an estimate that depends on your assumptions, and is neither a certified valuation nor investment advice.